Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 25 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05281471
- Conditions
- Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
- Locations
-
- The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- City of Hope Duarte, California, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
NCT07226427
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Highlands Oncology Group Springdale, Arkansas, United States
- Yale University New Haven, Connecticut, United States
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Conditions
- Platinum-resistant Ovarian Cancer
- Locations
-
- Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
- Hoag Newport Beach, California, United States
Recruiting
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT07489287
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
NCT06515613
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Endometrial Cancer, +20 more
- Locations
-
- University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
- Precision NextGen Oncology & Research Center Beverly Hills, California, United States
- SCRI at Denver Health Denver, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06321484
- Conditions
- Adnexal Diseases, Clear Cell Ovarian Carcinoma, Disease Attributes, +23 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06730347
- Conditions
- Clear Cell Adenocarcinoma of Cervix, Clear Cell Adenocarcinoma of Fallopian Tube, Clear Cell Adenocarcinoma of Ovary, +20 more
- Locations
-
- UCLA Los Angeles, California, United States
- Ochsner MD Anderson Cancer Center New Orleans, Louisiana, United States
- START Midwest Grand Rapids, Michigan, United States
- West Penn Allegheny Health Pittsburgh, Pennsylvania, United States
Recruiting
IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer
NCT05551507
- Conditions
- Platinum-resistant Ovarian Cancer
- Locations
-
- Anyang Cancer Hospital Anyang, China
- Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College Beijing, China
- Hunan Cancer Hospital Changsha, China
- Fujian Cancer Hospital Fuzhou, China
NCT06586957
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
- Locations
-
- University of Arkansas Medical School Little Rock, Arkansas, United States
- University of California - Los Angeles Los Angeles, California, United States
- UCSF San Francisco, California, United States
- SCRI at HealthOne Denver, Colorado, United States
NCT06547840
- Conditions
- Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
- Locations
-
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
- Edinburgh Cancer Research Centre Edinburgh, United Kingdom
- Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
- Cambridge University - Addenbrooke's Hospital London, United Kingdom
NCT06242470
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
- Locations
-
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
- START-New York Long Island Lake Success, New York, United States
- Providence Cancer Institute Portland, Oregon, United States
NCT06315491
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Honor Health Scottsdale, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
- Yale University School of Medicine New Haven, Connecticut, United States
NCT04787289
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Abbotsford Centre, BC Cancer Agency Abbotsford British Columbia, British Columbia, Canada
- BC Cancer - Vancouver Vancouver, British Columbia, Canada
Not Yet Recruiting
A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
NCT07708753
- Conditions
- Platinum-resistant Fallopian Tube Cancer, Platinum-resistant Ovarian Cancer, Platinum-resistant Primary Peritoneal Cancer
- Locations
-
Not specified
Not Yet Recruiting
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
NCT07604766
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
- Peking Union Medical College Hospital Beijing, China
- Chongqing University Cancer Hospital - Chongqing Cancer Hospital Chongqing, China
- Fujian Provincial Cancer Hospital Fujian, China
Completed
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
NCT05198804
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- Arizona Oncology Associates (Wilmot HOPE) - USOR Tucson, Arizona, United States
- Rocky Mountain Cancer Centers Aurora, Colorado, United States
- University of Colorado Aurora, Colorado, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
NCT05494580
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Sun Yat-sen University Cancer Cetntre Guangzhou, China
Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
NCT05483933
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
- Locations
-
- University of Arkansas for Medical sciences Little Rock, Arkansas, United States
- City of Hope Duarte, California, United States
- Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
- START Midwest Grand Rapids, Michigan, United States
NCT04374630
- Conditions
- Platinum-resistant Ovarian Cancer
- Locations
-
- Arizona Oncology Associates Phoenix, Arizona, United States
- Arizona Oncology Tucson, Arizona, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- Gynecology Oncology Associates Newport Beach Newport Beach, California, United States
NCT02090582
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
- Duke University Medical Center Durham, North Carolina, United States